ADMA Biologics Files 2024 10-K
Ticker: ADMA · Form: 10-K · Filed: Mar 18, 2025 · CIK: 1368514
| Field | Detail |
|---|---|
| Company | Adma Biologics, Inc. (ADMA) |
| Form Type | 10-K |
| Filed Date | Mar 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, biologics
TL;DR
ADMA Biologics dropped its 2024 10-K. Check financials.
AI Summary
ADMA Biologics, Inc. filed its 2024 10-K on March 18, 2025, reporting on its fiscal year ending December 31, 2024. The company, focused on biological products, is incorporated in Delaware and headquartered in Ramsey, NJ. This filing provides a comprehensive overview of its financial performance and business operations for the past fiscal year.
Why It Matters
This 10-K filing is crucial for investors and stakeholders to understand ADMA Biologics' financial health, operational performance, and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a biopharmaceutical company, ADMA Biologics faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the 10-K filing.)
- 2025-03-18 — Filing Date (The date ADMA Biologics submitted its 10-K to the SEC.)
Key Players & Entities
- ADMA BIOLOGICS, INC. (company) — Filer and subject of the 10-K
- 2024-12-31 (date) — Fiscal year end for the reported period
- 2025-03-18 (date) — Filing date of the 10-K
- Ramsey, NJ (location) — Company headquarters
- BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) (industry) — Company's Standard Industrial Classification
FAQ
What is the primary business of ADMA Biologics, Inc.?
ADMA Biologics, Inc. is primarily involved in the business of biological products, specifically classified under Standard Industrial Classification 2836.
When did ADMA Biologics file its 10-K for the fiscal year ending December 31, 2024?
ADMA Biologics filed its 10-K for the fiscal year ending December 31, 2024, on March 18, 2025.
Where is ADMA Biologics, Inc. headquartered?
ADMA Biologics, Inc. is headquartered at 465 State Route 17, Ramsey, NJ 07446.
What is the Central Index Key (CIK) for ADMA Biologics, Inc.?
The Central Index Key (CIK) for ADMA Biologics, Inc. is 0001368514.
What was the previous name of ADMA Biologics, Inc.?
The former company name was R&R ACQUISITION VI, INC, with a date of name change on July 7, 2006.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 18, 2025 regarding ADMA BIOLOGICS, INC. (ADMA).